Letter: anti-TNF therapy and intestinal resections in Crohn’s disease-are we just delaying the inevitable?-Reference-Cited by-同舟云学术

Letter: anti-TNF therapy and intestinal resections in Crohn’s disease-are we just delaying the inevitable?

Published:2019-09-18 Issue:7 Volume:50 Page:842-843
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Ashton James J.¹²^ORCID,Beattie R. Mark¹^ORCID

Affiliation:

1. Department of Paediatric Gastroenterology; Southampton Children’s Hospital; Southampton UK

2. Department of Human Genetics and Genomics; University of Southampton; Southampton UK

Funder

Action Medical Research

European Society for Clinical Nutrition and Metabolism

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15482/fullpdf

Reference9 articles.

1. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study;Murthy;Gut,2019

2. Increased prevalence of anti-TNF therapy in paediatric inflammatory bowel disease is associated with a decline in surgical resections during childhood;Ashton;Aliment Pharmacol Ther,2019

3. Surgery for children with Crohn’s disease: indications, complications and outcome;Blackburn;Arch Dis Child,2014

4. Mechanism of action of anti-TNF therapy in inflammatory bowel disease;Levin;J Crohn’s Colitis,2016

5. Genetic influences on the development of fibrosis in Crohn’s disease;Verstockt;Front Med,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent developments in the assessment and management of inflammatory bowel disease in childhood: a narrative review;Translational Pediatrics;2023-10

2. Risk of Post-Resection Recurrence in Pediatric Crohn Disease;Journal of Pediatric Gastroenterology & Nutrition;2022-04-19

3. Inflammatory bowel disease: long-term therapeutic challenges;Expert Review of Gastroenterology & Hepatology;2019-11-02